William Chase - Director at Intellia Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
NTLA on Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by William Chase since 7/15/2023

Holdings reported by William Chase for Intellia Therapeutics, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 26.7 K $881 K $32.99 Jun 12, 2024 Direct
Stock Option (right to buy) 11.5 K Jun 12, 2024 Direct Common Stock

Transactions reported by William Chase for Intellia Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership